Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial growth machinery is a broad, non-specific term encompassing the various molecular systems and complexes required for bacterial survival, replication, and proliferation. This includes the machinery for DNA replication (e.g., DNA gyrase), RNA transcription (RNA polymerase), protein translation (the 70S ribosome), and cell wall biosynthesis (e.g., penicillin-binding proteins). These systems are the primary targets for the majority of clinically used antibiotics, which exploit the structural and functional differences between bacterial and eukaryotic machinery to achieve selective toxicity. Because the term refers to a collection of distinct molecular targets rather than a single entity, it is generally considered a category of targets in pharmacology. Targeting these processes is essential for treating a wide range of bacterial infections, though the emergence of multi-drug resistant strains poses a significant challenge to modern medicine (Source: NIH, StatPearls, Wikipedia).
Inhibition of peptidoglycan synthesis, inhibition of 30S or 50S ribosomal subunits, inhibition of DNA gyrase and topoisomerase IV, and inhibition of RNA polymerase.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial growth machinery.